Document Detail

Adverse outcome of using tilmicosin in a lamb with multiple ventricular septal defects.
MedLine Citation:
PMID:  19337615     Owner:  NLM     Status:  MEDLINE    
A 15-day-old, 6.08 kg, lamb was injected subcutaneously with tilmicosin 15 mg/kg body weight. Approximately 15 min later, the lamb died. During necropsy, the heart was found to have multiple ventricular septal defects. Death was attributed to sudden heart failure due to the cardiac effects of tilmicosin in a heart having congenital defects.
Georgios Christodoulopoulos
Related Documents :
17255815 - Percutaneous closure of ventricular septal defects. state of the art.
18001355 - Myocardial asynchrony in patients with postinfarction intraventricular conduction defects.
8614145 - A one-way valved atrial septal patch: a new surgical technique and its clinical applica...
2970335 - Doppler color-flow imaging assessment of shunt size in atrial septal defect.
12556615 - Post-cardiac catheterization access site complications and low-molecular -weight hepari...
19544385 - Reduced l-arginine transport contributes to the pathogenesis of myocardial ischemia-rep...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian veterinary journal. La revue vétérinaire canadienne     Volume:  50     ISSN:  0008-5286     ISO Abbreviation:  Can. Vet. J.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-04-01     Completed Date:  2009-06-30     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  0004653     Medline TA:  Can Vet J     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  61-3     Citation Subset:  IM    
Clinic of Medicine, School of Veterinary Medicine, University of Thessaly, Karditsa, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Animals, Newborn
Death, Sudden, Cardiac / etiology,  veterinary*
Fatal Outcome
Heart Septal Defects, Ventricular / physiopathology,  veterinary*
Sheep Diseases / physiopathology*
Tylosin / adverse effects,  analogs & derivatives*
Reg. No./Substance:
1401-69-0/Tylosin; XL4103X2E3/tilmicosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Factors associated with the early detection of foot-and-mouth disease during the 2001 epidemic in th...
Next Document:  Cecal rupture in foals--7 cases (1996-2006).